Cormorant Asset Management, LP Repare Therapeutics Inc. Transaction History

Cormorant Asset Management, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$25.71 - $35.24 $9.35 Million - $12.8 Million	-363,766 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$30.1 - $34.85 $2.96 Million - $3.43 Million	-98,439 Reduced 21.3%	363,766 $11.3 Million
Q1 2021 May 17, 2021	BUY	$25.89 - $44.46 $4.2 Million - $7.21 Million	162,205 Added 54.07%	462,205 $14.2 Million
Q4 2020 Feb 16, 2021	SELL	$23.42 - $39.5 $1.14 Million - $1.92 Million	-48,567 Reduced 13.93%	300,000 $10.3 Million
Q3 2020 Nov 16, 2020	SELL	$21.55 - $33.92 $91,113 - $143,413	-4,228 Reduced 1.2%	348,567 $10.7 Million
Q2 2020 Aug 14, 2020	BUY	$30.8 - $32.99 $10.9 Million - $11.6 Million	352,795 New	352,795 $10.9 Million

35.4M

50K

300

Ticker RPTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,937,800
Market Cap $130M
Description
Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that foc...

Get notified when there are updates to the investment portfolio of Cormorant Asset Management, LP, based on Form 13F filings with the SEC.

Stay updated on Cormorant Asset Management, LP with notifications on news.